Eisai Co., Ltd. and Biogen Inc. announced that the National Medical Products Administration (NMPA) of China has approved the subcutaneous formulation (subcutaneous autoinjector: SC-AI), the anti-amyloid beta (Aβ)… read more.
Emergency Medicine & Intensive Care
Tens of millions of people suffer from traumatic brain injury every year worldwide, with almost 5 million deaths. Yet when it comes to improving clinical outcomes, new research… read more.
Quest Diagnostics announced two new developments for its Quest AD-Detect portfolio of blood-based biomarker tests for Alzheimer’s disease, with the goal of broadening access to quality blood tests… read more.
Egetis Therapeutics AB announced that its partner Fujimoto Pharmaceutical Corporation, which has an exclusive license agreement to develop and commercialize Emcitate (tiratricol) for the treatment of MCT8 deficiency… read more.
Emergency Medicine & Intensive Care
Airline emergency medical kits should include benzodiazepines so that cabin crew and responding clinicians can treat passengers who have a seizure mid-flight, according to a Viewpoint published in… read more.
Takeda announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of Orzeyful (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with… read more.
Epilepsy remains a major public health challenge, but its burden is changing in ways that reveal health inequalities. Global Burden of Disease Study 2021 (GBD 2021) data indicate… read more.
Intensive, long-term blood pressure-lowering treatment reduced the risk of recurrent stroke by 38%, without increasing serious adverse events, in people who have survived an intracerebral haemorrhage (ICH). The… read more.
Lantheus Holdings, Inc. announced FDA approval of TAUKLARIFY (florquinitau F 18 injection), also referred to as MK 6240, a radiodiagnostic agent indicated for positron emission tomography (PET) of… read more.
Older adults with cardiovascular disease (CVD) often have coexisting cognitive impairment and frailty, conditions that can significantly affect treatment decisions, recovery, independence and quality of life and should… read more.
JCR Pharmaceuticals announced its development plan in Japan for givinostat, a treatment for Duchenne muscular dystrophy (DMD), following consultation with the Pharmaceuticals and Medical Devices Agency (PMDA). Based… read more.
Having normal blood pressure, no diabetes and not smoking was associated with living nearly 13 years longer without dementia, according to a study published August 5, 2026, in Neurology® Open… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
